Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
Pathological fundus angiogenesis is a major cause of vision loss in retina diseases. Endostatin, a C-terminal fragment of collagen XVIII, is an endogenous anti-angiogenic protein. The present study aimed to investigate the in vitro and in vivo anti-angiogenic properties of two proteins: an N-termina...
Main Authors: | Yujing Bai, Min Zhao, Chunfang Zhang, Shanshan Li, Yun Qi, Bin Wang, Lvzhen Huang, Xiaoxin Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4224489?pdf=render |
Similar Items
-
Inhibition of the recombinant human endostatin adenavirus on experimental choroidal neovascularization in rats
by: Li-Juan Chen, et al.
Published: (2017-06-01) -
Comparison of endostatin(endostar)and avastin's inhibition effect on mice choroidal neovascularization
by: Jing Li, et al.
Published: (2014-06-01) -
An angiogenic role for adrenomedullin in choroidal neovascularization.
by: Susumu Sakimoto, et al.
Published: (2013-01-01) -
Is asthma related to choroidal neovascularization?
by: Yaoyao Sun, et al.
Published: (2012-01-01) -
Interactions between Endostatin and Vascular Endothelial Growth Factor (VEGF) and Inhibition of Choroidal Neovascularization
by: Chunhai Fan, et al.
Published: (2007-01-01)